-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/stem-cell-children_research-protocol.pdf
November 01, 2010 - Griscelli syndrome, type 2
Interferon-gamma receptor deficiencies
Leukocyte adhesion deficiency
Severe … alpha-Mannosidosis
Peroxisomal storage disorders
Adrenoleukodystrophy
Variable Allo
Osteopetrosis Severe … JRA),
systemic lupus erythematosus
(SLE), scleroderma, immune
cytopenias, Crohn’s
Upfront for
severe … transplant*"
10:16:06 73273
Other Autoimmune Diseases
#23 Search (#20 AND #13) NOT #5 AND (severe
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0277_03-10-2008.pdf
January 01, 2008 - Effective Health Care
Topic Number(s): 0059
Document Completion Date: 6-2-09
1
Results of Topic Selection Process & Next Steps
Bone marrow transplants (BMT) in children will go forward for refinement as a comparative
effectiveness or effectiveness review. The scope of this topic, including po…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/urinary-incontinence-treatment_research-protocol.pdf
September 30, 2010 - urodynamic stress incontinence
Sandvik’s severity index103
Slight incontinence
Moderate incontinence
Severe
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-pregnancy-postpartum_disposition-comments.pdf
July 08, 2014 - Some pregnant
women with depression have an illness so severe that
they cannot be free from antidepressant … indication is certainly a concern for observational
studies – where it is possible that women with more severe … symptoms receive antidepressants while those with less severe
symptoms do not. … Without a comment
about the severity of depression - the SSRI group may
have represented more severe
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/medicine-safety-call-center_research.pdf
September 01, 2007 - In the case of severe adverse drug effects and MedWatch
report is filed by the Pharmacist.
-
effectivehealthcare.ahrq.gov/sites/default/files/it-architecture-for-post-marketing-surveillance-arizona-cert.pdf
September 01, 2007 - In the case of severe adverse drug effects and MedWatch
report is filed by the Pharmacist.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prioritized-research-agenda.pdf
October 01, 2021 - What is the comparative effectiveness of treatment approaches for severe TRD (defined
as lack of response
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/infantile-hemangioma_executive.pdf
January 01, 2016 - 5 months of age.6
Furthermore, some lesions are particularly aggressive or
morbid and can cause severe … While harms reported in studies of beta-blockers were
typically not severe, only one comparative study29 … Propranolol for severe
infantile hemangiomas: follow-up report. … Propranolol treatment for severe infantile hemangiomas: a single-
centre 3-year experience. … Propranolol for severe hemangiomas of infancy. N Engl J Med
2008 Jun 12;358(24):2649-51.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children-future_research.pdf
February 01, 2012 - Psychotic disorders Adults
Haloperidol
Schizophrenia
Adults Tourette syndrome
Hyperactivity
Severe … EPS is a group of movement disorders,
including acute dystonic reactions (severe spasms of various muscle … The most severe antipsychotic-associated potential side effect
is neuroleptic malignant syndrome (NMS … eating disorder not otherwise specified), tic disorders (Tourette
syndrome), or nondisorder-specific severe … Psychotic disorders Adults
Haloperidol
Schizophrenia
Adults Tourette syndrome
Hyperactivity
Severe
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1306.pdf
October 01, 2014 - Clinical trials: Investigators concluded from a 2010 Reclaim DBS Therapy trial of 10 patients
with severe … Now, ketamine is
being investigated for the intravenous treatment of treatment-resistant or acute severe
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-cough_research-protocol.pdf
October 22, 2012 - All
dosages
As needed Oral Approved
150+ more brands Diphenhydramine
Theraflu Nighttime
Severe
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-epilepsy-amended-protocol.pdf
March 07, 2021 - 1 Childhood
Epilepsy
'benign childhood epilepsy'/exp OR 'childhood absence
epilepsy'/exp OR 'severe
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-supplementary-app-i.xlsx
January 01, 2019 - events analyzed for potential modification.
40905 CRITICS Age Yes Grade 3 to 5 adverse events: Any severe
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/procalcitonin-future_research.pdf
August 01, 2014 - Placebo
Controlled Trial of
Sodium Selenite and
Procalcitonin Guided
Antimicrobial Therapy in
Severe … Placebo
Controlled Trial of
Sodium Selenite and
Procalcitonin Guided
Antimicrobial Therapy in
Severe … For patients with severe immunosuppression, is PCT
indicator of bacterial infection? … For patients with severe immunosuppression, what is the
comparative effectiveness of clinical criteria … For patients with severe immunosuppression, what is the
comparative effectiveness of clinical criteria
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-hemangioma_consumer.pdf
June 01, 2016 - These problems are rare but may be
permanent if the IH is not treated early.
» For these more severe
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/depression-childhood-protocol.pdf
August 06, 2018 - In sum, most guidelines recommend treatment
type depending on level of severity (mild, moderate, severe … medications or a combination of psychotherapy and SSRIs is
recommended for patients with moderate or severe … for
patients with mild MDD; referral to mental
health specialists for patients with moderate to
severe … these initial
strategies or those with complicated or
depression symptoms accompanied by moderate
to severe … possible for some youth who might
have a history of relapse/recurrence after
treatment, chronic or severe
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/stem-cell-children-future_research.pdf
February 01, 2012 - Neurodevelopmental outcomes
appear similar for both HSCT and enzyme replacement therapy for the severe … For the severe form of the disease
neither HSCT nor ERT appear to offer a benefit relative to disease … The autoimmune diseases evaluated in this report were: Type 1 diabetes
mellitus, and severe/refractory … gangliosidosis, infantile Tay-Sachs, juvenile
ceroid lipofuscinosis, Type 1 diabetes mellitus, and severe … CHRON’S DISEASE Hematopoietic Stem
Cell Support in
Patients With Severe
Crohn's Disease.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-update_disposition-comments.pdf
August 16, 2016 - Also,
need to differentiate between rates of ALL RAS and
moderate to severe RAS (generall accepted … patients likely to benefit from
intervention based upon the clinical series--- rapid loss
of GFR, severe … studies may be needed in patients at
higher likelihood of potential benefit---rapid loss of GFR,
severe
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_6-user-guide-to-ocer_130129.pdf
October 30, 2012 - representing a percentage of area
involvement.4 The final calculated score ranges
from 0 (no disease) to 72 (severe … Severe psoriasis--
oral therapy with a new retinoid. Dermatologica.
1978;157(4):238-44.
5. U.S.
-
effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1312.pdf
December 01, 2013 - cholinesterase inhibitors, and, depending on the drug, are used to treat AD
symptoms for mild to severe … Memantine, an N-methyl-D-aspartate receptor
antagonist, is approved to treat the symptoms of moderate to severe